Qiang's cv

Academic CV of Qiang Feng, PhD - Assistant Professor of Biomedical Engineering at UT Southwestern Medical Center, specializing in microfluidics, nanotechnology, and cancer therapeutics.

General Information

Full Name Qiang Feng, PhD
Current Position Assistant Professor
Institution University of Texas Southwestern Medical Center
Department Biomedical Engineering, Simmons Comprehensive Cancer Center
Languages English, Chinese

Summary of Contributions

  • My research centers on exploring the abundance and immunological functions of key metabolites in tumors. By designing multi-chromatic pH nanosensors with high spatial resolution, I uncovered the presence of severely polarized acidity (pHe<5.3) around tumor cells—more than one order of magnitude higher than previous understanding (Nature Biomed. Eng. 2024). - By combining insights from cancer biology, clinical observations, and immune metabolism, I demonstrated that severe acidity is an underestimated immunosuppressor, while sodium lactate, as its anionic counterpart, plays a previously unrecognized immune-protective role (Nature Commun. 2022). I further led the development of multiple acidity-targeted immunotherapy nanodrugs and tumor metabolism-regulating immune adjuvants based on these findings. To date, I have published over 30 peer-reviewed papers in leading journals such as Nature Biomed. Eng. and Nature Commun., accumulating over 4,000 citations. I have also filed three patents for my discoveries. In addition to the scientific innovation, I have also mentored students from diverse backgrounds and will continue to train young scientists, providing them with the tools and mentorship to succeed in cancer research.

Education

  • 2014-2017
    PhD in Nanoscience and Technology
    National Center for Nano Science and Technology, Beijing, China
    • Thesis: Microfluidics-mediated Assembly of Functional Nanoparticles for Cancer-related Applications
    • Advisors: Profs. Xingyu Jiang and Jiashu Sun
  • 2012-2014
    MS in Pharmaceutics
    Peking University, Beijing, China
    • Thesis: Surface Modified Core-shell Type Nanoparticles for The Co-delivery of Paclitaxel and SiRNA
    • Advisor: Prof. Jiancheng Wang
  • 2008-2012
    BS in Pharmaceutical Sciences
    Peking University, Beijing, China

Professional Experience

  • 2024 - Present
    Assistant Professor
    University of Texas Southwestern Medical Center, Dallas, United States
    • Leading research in tumor immune metabolism at single cell resolution
    • Developing novel nanodrugs and immune adjuvants for cancer therapy
    • Mentoring graduate students and postdoctoral researchers
  • 2023 - 2024
    Research Scientist
    University of Texas Southwestern Medical Center, Dallas, United States
    • Developed tumor-targeted cytokine therapy with large therapeutic window
  • 2017 - 2023
    Postdoctoral Fellow
    University of Texas Southwestern Medical Center, Dallas, United States
    • Advisor: Prof. Jinming Gao
    • Tumor Immune Metabolism: Delineated the spatial and functional heterogeneity of lactic acid
    • Cytokine Therapy: Developed tumor-targeted cytokine therapy with large therapeutic window

Research Experience

  • 2014 - 2017
    Graduate Researcher
    National Center for Nano Science and Technology, Beijing, China
    • Advisors: Profs. Xingyu Jiang and Jiashu Sun
    • Microfluidics: Developed microfluidic chips for size-controlled fabrication of nanoparticles
    • Bio-nano Interactions: Investigated the impact of nanoparticle structure on biological functionalities
  • 2012 - 2014
    Graduate Researcher
    Peking University, Beijing, China
    • Advisor: Prof. Jiancheng Wang
    • Drug delivery: Engineered liposomes for tumor targeted delivery of chemotherapy agents and siRNA

Research Interests

  • Tumor Immune Metabolism
    • Probing metabolite dynamics at the single-cell level.
    • Investigating the immunological functions of key metabolites.
  • Cancer Immunotherapy
    • Acidity-targeted immunotherapy
    • Tumor metabolism-regulating immune adjuvants
    • Cytokine therapy
  • Microfluidics and Nanotechnology
    • Microfluidic synthesis of functional nanoparticles
    • Strucuture-controlled fabrication of nanoparticles
    • Bio-nano interactions and biological functionalities

Selected Publications

  • 2024
    Severely polarized extracellular acidity around tumour cells
    Nature Biomedical Engineering
    • Uncovered severely polarized acidity (pHe<5.3) around tumor cells
    • More than one order of magnitude higher than previous understanding
  • 2022
    Lactate increases stemness of CD8+ T cells to augment anti-tumor immunity
    Nature Communications
    • Demonstrated lactate's role in enhancing CD8+ T cell stemness
    • Revealed immune-protective role of sodium lactate
  • 2021
    Tumor-Targeted Inhibition of Monocarboxylate Transporter 1 Improves T-Cell Immunotherapy
    Advanced Healthcare Materials
    • Developed MCT1 inhibition strategy for improved immunotherapy
    • Enhanced T-cell function in solid tumors
  • 2019
    Transistor-like Ultra-pH-Sensitive Polymeric Nanoparticles
    Accounts of Chemical Research
    • Pioneered ultra-pH-sensitive nanoparticle technology
    • Advanced drug delivery systems for cancer therapy
  • 2017
    One-Step Microfluidic Synthesis of Nanocomplex with Tunable Rigidity
    Small
    • Developed microfluidic synthesis of tunable rigidity nanoparticles
    • Acid-switchable surface charge for enhanced cellular uptake
  • 2015
    Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents delivery
    Angewandte Chemie International Edition
    • Pioneered microfluidic approach for encapulation of hydrophilic reagents

Honors and Awards

  • 2022
    • Young Investigator Award, 37th Society for Immunotherapy of Cancer Annual Meeting
  • 2016
    • Merit Student, Chinese Academy of Sciences
  • 2015
    • Graduate Student Award, Chinese Pharmaceutical Conference
  • 2013
    • Daewoong Scholarship, Peking University
  • 2011
    • Daewoong Scholarship, Peking University
    • ShuRen Scholarship, Peking University
  • 2009
    • May Fourth Scholarship, Peking University
    • Merit Student, Peking University

Patents

  • 2015
    A Microfluidic Chip and Method of Use Thereof in the Preparation of Nanocapsule
    CN104549585B
    • Chinese patent for microfluidic nanocapsule preparation technology
  • 2021
    pH Responsive Block Copolymer Compositions and Micelles that Inhibit MCT 1 and Related Protein
    US20210338579A1
    • US patent application for pH-responsive drug delivery systems
  • 2022
    Ultra pH-sensitive Micelles Encapsulating Cytokines for Treatment of Cancer
    PCT/US2022/079899
    • International patent application for pH-sensitive cytokine delivery

Presentations and Posters

  • Oral Presentations
    • Immuno-oncology Translational Network Semi-Annual Meeting, Gaithersburg, United States (2023)
    • 37th Society of Immunotherapy of Cancer Annual Conference, Boston, United States (2022)
    • International Conference of Microfluidics and Nanofluidics, Dalian, China (2016)
    • Chinese Pharmaceutical Conference, Hangzhou, China (2015)
  • Poster Presentations
    • Keystone Symposia Conference Single Cell Biology, Breckenridge, United States (2019)
    • ChinaNano 2017, Beijing, China (2017)
    • NanoDDS16, Baltimore, United States (2016)
    • ChinaNano 2015, Beijing, China (2015)
    • ChinaNanomedicine 2015, Hangzhou, China (2015)

Services

  • Journal Reviewer
    • ACS Applied Materials and Interface
    • Theranostics
    • Nanoscale
    • Trends in Analytical Chemistry
    • Journal of Material Sciences B
    • International Journal of Nanomedicine
    • Scientific Reports
    • RSC Advances
    • Electrophoresis
    • MedChemComm
    • Journal of Materials Science & Technology
    • Fibers and Polymers
    • Advanced Science
    • Molecular Cancer
  • Guest Topic Editor
    • Frontiers in Pharmacology. 'Drug Discovery and Nano Delivery of Natural Products'
    • Frontiers in Immunology. 'Decoding the immunotherapy paradox: integrative approaches for balancing efficacy and immunotherapy-associated adverse events'